Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Oxidative Stress
90%
Endoplasmic Reticulum Stress (ER stress)
72%
Diabetes
60%
Experimental Autoimmune Myocarditis
51%
Apoptosis
50%
Diabetic Cardiomyopathy
49%
Heart Failure
47%
Dilated Cardiomyopathy
46%
Aldehyde Dehydrogenase 2 (ALDH2)
46%
Curcumin
45%
Inflammation
41%
Cardiac Function
40%
Daunorubicin
40%
Beneficial Effects
38%
Cardiomyocyte Apoptosis
37%
Antioxidant
36%
Angiotensin II Type 1 Receptor (AT1R)
35%
Diabetic
33%
Mitogen-activated Protein Kinase
33%
14-3-3 Protein
32%
Streptozotocin-induced Diabetic Rats
32%
Cardiotoxicity
31%
Olmesartan
30%
Cardiac Remodeling
30%
Cardiac Dysfunction
29%
Angiotensin II (Ang II)
28%
4-hydroxynonenal (4-HNE)
28%
Cardiac Fibrosis
27%
Angiotensin Receptor Blockers
26%
Streptozotocin-induced
26%
Fibrosis
25%
Protein Expression
25%
Heart Failure with Preserved Ejection Fraction (HFpEF)
25%
Telmisartan
25%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
25%
Diabetic Nephropathy
23%
Atopic Dermatitis
23%
Inflammatory Cytokines
22%
Nephrotoxicity
22%
High Mobility Group Box 1 (HMGB1)
22%
Dominant Negative
21%
Hyperglycemia
21%
Type 1 Diabetes Mellitus (T1DM)
20%
Stress-induced
20%
Transgenic Mice
20%
Mouse Model
20%
Acute Colitis
20%
Dextran Sulfate Sodium
20%
Caspase-12
19%
Endothelial Dysfunction
18%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Congestive Heart Failure
83%
Streptozotocin
62%
Inflammation
61%
Diabetic Cardiomyopathy
51%
Antioxidant
50%
Experimental Autoimmune Myocarditis
49%
Congestive Cardiomyopathy
46%
Angiotensin II
41%
Receptor
40%
Daunorubicin
40%
Curcumin
40%
Diseases
38%
Aldehyde Dehydrogenase Isoenzyme 2
37%
4 Hydroxynonenal
36%
Heart Muscle Fibrosis
33%
Heart Ventricle Remodeling
33%
Cardiotoxicity
32%
Protein 14 3 3
32%
Cytokine
32%
Colitis
31%
Olmesartan
30%
Hyperglycemia
29%
Mitogen Activated Protein Kinase
28%
Fibrosis
26%
Myocarditis
26%
Angiotensin Receptor Antagonist
25%
Mouse Model
25%
Telmisartan
25%
Diabetic Nephropathy
25%
Atopic Dermatitis
23%
Cardiovascular Disease
23%
Nephrotoxicity
22%
Mitogen Activated Protein Kinase P38
21%
Transgenic Mouse
21%
Peroxisome Proliferator Activated Receptor
20%
Senescence Accelerated Mouse
20%
Dextran Sulfate
20%
Acetylcholinesterase
19%
Heart Injury
18%
Messenger RNA
18%
Liver Injury
16%
Lung Fibrosis
16%
Western Blot
16%
Doxorubicin
15%
Mitogen Activated Protein Kinase 3
15%
Heart Failure with Preserved Ejection Fraction
15%
Heart Ventricle Hypertrophy
15%
Torasemide
15%
Carvedilol
15%
Medicine and Dentistry
Diabetes
42%
Diabetes Mellitus
39%
Congestive Heart Failure
38%
Programmed Cell Death
37%
Oxidative Stress
27%
Antioxidant
26%
Endoplasmic Reticulum Stress
26%
Heart Function
24%
Diabetic Cardiomyopathy
20%
Aldehyde Dehydrogenase Isoenzyme 2
20%
Heart Failure with Preserved Ejection Fraction
20%
Diseases
19%
extracellular signal regulated kinase
18%
Endothelial Cell
17%
Experimental Autoimmune Myocarditis
16%
Pulmonary Hypertension
16%
Kampo
15%
Pulmonary Fibrosis
15%
Receptor
14%
Angiotensin II
14%
Mitogen Activated Protein Kinase P38
14%
Endothelial Dysfunction
13%
Fibrosis
12%
Cell Signaling Pathway
12%
Cardiac Muscle Cell
12%
Pathophysiology
12%
Edaravone
12%
Hyperglycemia
11%
microRNA
11%
Heart Right Ventricle Failure
10%
Nephrotoxicity
10%
Right Ventricle
10%
Liposomal Daunorubicin
10%
Olmesartan
10%
Gene Therapy
10%
Atopic Dermatitis
10%
Stress Echocardiography
10%
Restylane
10%
Quercetin
10%
Angiogenesis
9%
Heart Disease
9%
Idiopathic Pulmonary Fibrosis
8%
4 Hydroxynonenal
7%
Heart Ventricle Remodeling
7%
Transgenic Mouse
7%
14-3-3 Protein
7%
Disease
7%
Mast Cell
7%
Cardiovascular Disease
7%
Colitis
7%